Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

497 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
NUDT15 variants confer high incidence of second malignancies in children with acute lymphoblastic leukemia.
Yoshida M, Nakabayashi K, Yang W, Sato-Otsubo A, Tsujimoto SI, Ogata-Kawata H, Kawai T, Ishiwata K, Sakamoto M, Okamura K, Yoshida K, Shirai R, Osumi T, Moriyama T, Nishii R, Takahashi H, Kiyotani C, Shioda Y, Terashima K, Ishimaru S, Yuza Y, Takagi M, Arakawa Y, Kinoshita A, Hino M, Imamura T, Hasegawa D, Nakazawa Y, Okuya M, Kakuda H, Takasugi N, Inoue A, Ohki K, Yoshioka T, Ito S, Tomizawa D, Koh K, Matsumoto K, Sanada M, Kiyokawa N, Ohara A, Ogawa S, Manabe A, Niwa A, Hata K, Yang JJ, Kato M. Yoshida M, et al. Among authors: ohara a. Blood Adv. 2021 Dec 14;5(23):5420-5428. doi: 10.1182/bloodadvances.2021005507. Blood Adv. 2021. PMID: 34662904 Free PMC article.
Plasma asparaginase activity, asparagine concentration, and toxicity after administration of Erwinia asparaginase in children and young adults with acute lymphoblastic leukemia: Phase I/II clinical trial in Japan.
Ogawa C, Taguchi F, Goto H, Koh K, Tomizawa D, Ohara A, Manabe A. Ogawa C, et al. Among authors: ohara a. Pediatr Blood Cancer. 2017 Sep;64(9). doi: 10.1002/pbc.26475. Epub 2017 Feb 28. Pediatr Blood Cancer. 2017. PMID: 28244643 Clinical Trial.
An international retrospective study for tolerability of 6-mercaptopurine on NUDT15 bi-allelic variants in children with acute lymphoblastic leukemia.
Tanaka Y, Yeoh AEJ, Moriyama T, Li CK, Kudo K, Arakawa Y, Buaboonnam J, Zhang H, Liu HC, Ariffin H, Chen Z, Kham SKY, Nishii R, Hasegawa D, Fujimura J, Keino D, Kondoh K, Sato A, Ueda T, Yamamoto M, Taneyama Y, Hino M, Takagi M, Ohara A, Ito E, Koh K, Hori H, Manabe A, Yang JJ, Kato M. Tanaka Y, et al. Among authors: ohara a. Haematologica. 2021 Jul 1;106(7):2026-2029. doi: 10.3324/haematol.2020.266320. Haematologica. 2021. PMID: 33504140 Free PMC article. No abstract available.
Long-term outcome of 6-month maintenance chemotherapy for acute lymphoblastic leukemia in children.
Kato M, Ishimaru S, Seki M, Yoshida K, Shiraishi Y, Chiba K, Kakiuchi N, Sato Y, Ueno H, Tanaka H, Inukai T, Tomizawa D, Hasegawa D, Osumi T, Arakawa Y, Aoki T, Okuya M, Kaizu K, Kato K, Taneyama Y, Goto H, Taki T, Takagi M, Sanada M, Koh K, Takita J, Miyano S, Ogawa S, Ohara A, Tsuchida M, Manabe A. Kato M, et al. Among authors: ohara a. Leukemia. 2017 Mar;31(3):580-584. doi: 10.1038/leu.2016.274. Epub 2016 Oct 4. Leukemia. 2017. PMID: 27698447
Significance of the complete clearance of peripheral blasts after 7 days of prednisolone treatment in children with acute lymphoblastic leukemia: the Tokyo Children's Cancer Study Group Study L99-15.
Manabe A, Ohara A, Hasegawa D, Koh K, Saito T, Kiyokawa N, Kikuchi A, Takahashi H, Ikuta K, Hayashi Y, Hanada R, Tsuchida M; Tokyo Children's Cancer Study Group. Manabe A, et al. Among authors: ohara a. Haematologica. 2008 Aug;93(8):1155-60. doi: 10.3324/haematol.12365. Epub 2008 Jun 2. Haematologica. 2008. PMID: 18519521 Free article.
The utility of performing the initial lumbar puncture on day 8 in remission induction therapy for childhood acute lymphoblastic leukemia: TCCSG L99-15 study.
Hasegawa D, Manabe A, Ohara A, Kikuchi A, Koh K, Kiyokawa N, Fukushima T, Ishida Y, Saito T, Hanada R, Tsuchida M; Tokyo Children's Cancer Study Group. Hasegawa D, et al. Among authors: ohara a. Pediatr Blood Cancer. 2012 Jan;58(1):23-30. doi: 10.1002/pbc.22965. Epub 2011 Jan 19. Pediatr Blood Cancer. 2012. PMID: 21254378 Clinical Trial.
No impact of high-dose cytarabine and asparaginase as early intensification with intermediate-risk paediatric acute lymphoblastic leukaemia: results of randomized trial TCCSG study L99-15.
Kato M, Koh K, Manabe A, Saito T, Hasegawa D, Isoyama K, Kinoshita A, Maeda M, Okimoto Y, Kajiwara M, Kaneko T, Sugita K, Kikuchi A, Tsuchida M, Ohara A. Kato M, et al. Among authors: ohara a. Br J Haematol. 2014 Feb;164(3):376-83. doi: 10.1111/bjh.12632. Epub 2013 Oct 26. Br J Haematol. 2014. PMID: 24164537 Free article. Clinical Trial.
Significance of CD66c expression in childhood acute lymphoblastic leukemia.
Kiyokawa N, Iijima K, Tomita O, Miharu M, Hasegawa D, Kobayashi K, Okita H, Kajiwara M, Shimada H, Inukai T, Makimoto A, Fukushima T, Nanmoku T, Koh K, Manabe A, Kikuchi A, Sugita K, Fujimoto J, Hayashi Y, Ohara A. Kiyokawa N, et al. Among authors: ohara a. Leuk Res. 2014 Jan;38(1):42-8. doi: 10.1016/j.leukres.2013.10.008. Epub 2013 Oct 22. Leuk Res. 2014. PMID: 24231528
497 results